LITTLE RIVER, S.C.--(BUSINESS WIRE)--PCT LTD (OTC Pink: PCTL) ("PCTL") is pleased to announce they have obtained a large pre-paid order from an existing sub-registrant in the Midwestern United States for 10,000 gallons of a specific fluid solution, with regular, recurring orders expected to follow.
PCT LTD CEO, Gary Grieco commented, “Our customer is ramping up their business to meet new contracts and we’re here to help them meet the growing demand.”
PCT LTD has been attracting increased attention as of late due to their Annihilyzer® Infection Control System which is currently installed in 9 US hospitals and 1 in the United Kingdom. However, its flagship Annihilyzer® product is far from the company’s only source of revenue. PCT LTD also generates revenue from the sale of equipment, the sale of fluids, in addition to licensing and royalty fees from its sub-registrants, distributors, and other customers.
With the company’s existing US EPA registration, PCT LTD has licensed a select number of companies as sub-registrants. Using PCT’s US EPA registration, the company licenses the use or sale of its proprietary products, including fluids such as Hydrolyte® and Hydrolyte® generators. Royalty agreements are also part of PCT’s revenue model and are often, though not exclusively, negotiated on a per gallon basis with sub-registrants.
Having multiple revenue streams is an important focus of the company’s business model, explains PCT Corp. President Bill Prince. “We’ve been active in our efforts to expand our network of quality sub-registrants and distributors in order to facilitate strategic growth. With multiple revenue streams, we’re able to achieve these goals more efficiently.”
PCT LTD currently has three active sub-registrants in two US states and one in Puerto Rico. The company currently has distributors in 3 US states. Collaborative and other agreements are in place with other complimentary business “partners.” Additional sales and installations are expected to be announced in coming weeks as the company expands its operations and continues to build on its current growth trajectory.
In a recent interview with the Stock Day Media Podcast, CEO Gary Grieco discussed the effectiveness of the product, competitive advantages over other cleaning solutions, and provided an update on the company’s current growth. Highlights include numerous international inquiries, transitioning to operating profit, and record revenue flow in the first quarter of 2020.
“One of the big problems with any small company is profitability. I will go out on a limb and say that we will be profitable in the month of March. We will have a record first quarter.” – Gary Grieco, CEO.
At the conclusion of the episode, Grieco and host Everett Jolly agreed to have Gary back on the show in the coming weeks to provide an additional update.
To hear the complete interview with Stock Day host Everett Jolly follow the link to the podcast here: PCT LTD Discusses Their Unique Annihilyzer Disinfecting System and Impact of the Coronavirus. This podcast is also available on The Stock Day Media Website in addition to iTunes and other audio platforms.
For additional information, please visit http://www.para-con.com.
About PCT LTD:
PCT LTD ("PCTL") focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the recurrence of orders, the success of its new distributors; the results of testing in the U.K; PCTL's and its subsidiary's business prospects; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.